Wang L, Lubin JH, Zhang SR, Metayer C, Xia Y, Brenner A, Shang B, Wang Z, Kleinerman RA: Lung cancer and environmental tobacco smoke in a non-industrial area of China
Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice
Sources PubMed Central (PMC / NIH) - European Commission asked to investigate use of snus to reduce smoking ScienceDirect - Risk assessment of snus use UK Government (gov.uk) - Bringing goods into the UK for personal use UK Legislation - The Tobacco for Oral Use (Safety) Regulations 1992 HMRC - Excise Notice 476: Tobacco Products Duty - Oral Snuff Classification ResearchGate - Oral use of Swedish moist snuff (snus) and risk for cancer iCliniq - Snus: Cancer Risk and Side Effects Global State of Tobacco Harm Reduction (GSTHR) - How snus is replacing smoking in Norway Disclaimer: The content presented on www.alternix.com is for informational purposes only and is centered around nicotine pouches and heated tobacco productsalternatives to traditional smoking methods
It causes more than lung cancer based on current evidence, it can cause cancers of the mouth and throat, voice box, esophagus, stomach, kidney, pancreas, liver, bladder, cervix, colon and rectum, and a type of leukemia (acute myeloid leukemia)
Bad breath also known as halitosis affects nearly one in four people worldwide
